VeriSIM Life Enters into Collaboration Agreement with Mayo Clinic to Jointly Advance Drug Discovery and Development Programs

VeriSIM Life (VeriSIM), a leading artificial intelligence (AI)-enabled company providing services to de-risk R&D decision making for breakthrough drug development, announced that it has entered into a collaboration with Mayo Clinic to improve the preclinical translation of promising drug candidates.

AI and ML News: Why SMBs Shouldn’t Be Afraid of Artificial Intelligence (AI)

“We are excited to expand our common mission and work with the world’s top research hospital and its drug discovery programs.”

Under the terms of the collaboration agreement, VeriSIM will leverage its proprietary BIOiSIM platform and Translational Index approach to reduce the number of outsourced preclinical experiments and help de-risk R&D decisions early-on to ensure expedited development of novel, safe and highly efficacious drugs.

Top Artificial Intelligence Insights: Determining the Potential of Your AI Algorithm Starts with Measurement

VeriSIM will engage Mayo Clinic physician researchers in key disease areas including oncology, hematology, bone/joint-disorders, and neurological diseases.

“This collaboration will explore the full potential of our combined approach to developing best-in-class drug candidates to serve patients’ unmet needs,” said Dr. Jo Varshney, founder and CEO of VeriSIM Life. “We are excited to expand our common mission and work with the world’s top research hospital and its drug discovery programs.”

Dr. Jo Varshney, DVM and PhD, founded VeriSIM Life in 2017 alongside a cross-functional team of pharmaceutical scientists, software engineers and AI/ML and simulation experts. VeriSIM offers unprecedented value for the drug development industry by reducing the number of drug compounds likely to treat or cure specific illnesses and diseases.

Mayo Clinic participated in VeriSIM’s Series A financing and has financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Read More About AI News : AI Innovation Supports Rural and Remote Internet Connectivity

[To share your insights with us, please write to sghosh@martechseries.com]